Management of immune thrombocytopenic purpura in children

Reviews in Clinical and Experimental Hematology

Volumn 5, Issue 3, 2001, Pages 201-221

  Gadner, Helmut ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISONE; RHESUS D ANTIBODY;

ACUTE DISEASE; BRAIN HEMORRHAGE; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; HOSPITALIZATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LAPAROSCOPY; PROBABILITY; RELIABILITY; REMISSION; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SPLENECTOMY; TREATMENT PLANNING;

CHILD; DISEASE MANAGEMENT; DISEASE PROGRESSION; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTRACRANIAL HEMORRHAGES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RHO(D) IMMUNE GLOBULIN; SPLENECTOMY;

EID: 0035467619     PISSN: 11270020     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-0734.2001.00040.x     Document Type: Review

References (80)

1. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines
2. Management of childhood idiopathic thrombocytopenic purpura
3. Immune thrombocytopenic purpura in childhood in Norway: A prospective, population-based registration
4. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for The American Society of Hematology
5. Guidelines for management of idiopathic thrombocytopenic purpura
6. Acute immune thrombocytopenia in childhood. Are we treating the platelet count?
7. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment
8. Intercontinental childhood ITP registry
9. Management of chronic immune thrombocytopenic purpura in children and adults
10. Idiopathic thrombocytopenic purpura
11. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: Results of a survey of practicing pediatric hematology/oncology specialists
12. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednis(ol)one treatment
13. Current management issues of childhood and adult immune thrombocytopenic purpura (ITP)
14. Idiopathic thrombocytopenic purpura in childhood
15. Idiopathic thrombocytopenic purpura: Beyond consensus
16. Idiopathic thrombocytopenic purpura in children
17. Approach to the investigation and management of immune thrombocytopenic purpura in children
18. Immunologic aspects in the pathogenesis and treatment of immune thrombocytopenic purpura in children
19. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood
20. Chronic idiopathic thrombocytopenic purpura: Incidence, treatment, and outcome
21. Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden
22. Epstein-Barr virus associated with immune thrombocytopenic purpura in childhood: A retrospective study
23. Idiopathic thrombocytopenic purpura and MMR vaccine
24. Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura
25. Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection
26. Phenytoin-induced thrombocytopenia treated with intravenous immune globulin
27. Heparin-induced thrombocytopenia in children
28. Thrombocytopenia secondary to high valproate levels in children with epilepsy
29. Type IIB von Willebrand's disease with probable autosomal recessive inheritance and presenting as thrombocytopenia in infancy
30. Reticulated platelet counts in the diagnosis of acute immune thrombocytopenic purpura
31. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura
32. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia?
33. Short-course oral prednis(ol)one therapy in children presenting with acute immune thrombocytopenic purpura (ITP)
34. Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and long-term outcome
35. Intracranial haemorrhage in idiopathic thrombocytopenic purpura
36. Randomised trial of intravenous immunglobulin G, intravenous anti-D, and oral prednis(ol)one in childhood acute immune thrombocytopenic purpura
37. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood
38. Intracranial hemorrhage in children with immune thrombocytopenic purpura
39. Initial management of immune thrombocytopenic purpura in children: Is supportive counseling without therapeutic intervention sufficient?
40. Prednis(ol)one therapy for children with newly diagnosed idiopathic thrombocytopenic purpura
41. Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity
42. Steroid treatment of idiopathic thrombocytopenic purpura in children
43. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura
44. Pulsed highdose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura
45. A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood
46. Oral cyclic megadose methylprednis(ol)one therapy for chronic immune thrombocytopenic purpura in childhood
47. Retrospective analysis of 78 children with chronic idiopathic thrombocytopenic purpura: Follow-up from 1976 to 1996
48. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednis(ol)one, intravenous immunoglobulin, or the combination of both
49. Response to "Treatment of childhood chronic ITP"
50. High-dose oral dexamethasone therapy for chronic childhood idiopathic thrombocytopenic purpura
51. Treatment options for chronic immune (idiopathic) thrombocytopenia purpura in children
52. Response of resistant idiopathic thrombocytopenic purpura to pulsed highdose dexamethasone therapy
53. Immune thrombocytopenic purpura ITP
54. Acute immune thrombocytopenic purpura: A comparative study of very high oral doses of methylprednis(ol)one and intravenously administered immune globulin
55. A prospective, randomized trial of high dose intravenous immune globulin G therapy, oral prednis(ol)one therapy, and no therapy in childhood acute immune thrombocytopenic purpura
56. Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura
57. Behandlung der akuten immunthrombozytopenie des kindesalters mit einer einzeldosis immunglobulin
58. Risks and benefits of intravenous immunoglobulin treatment in children
59. Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D)
60. Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous Rho (D) immune globulin
61. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients
62. Efficacy, safety, and dose-response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children
63. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D
64. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin
65. Immunologic effects of anti-D (WinRho-SD) in children with immune thrombocytopenic purpura
66. Intravenous anti-D immunoglobulin for childhood acute immune thrombocytopenic purpura
67. Overview of idiopathic thrombocytopenic purpura: New approach to refractory patients
68. In patients with ITP, does 75 μg/kg of IV anti-D increase the platelet count faster than 50 μg/kg?
69. Acute onset hemoglobinemia and/or hemoglobinuria and sequel following Rh(o)(D) immune globulin intranvenous administration in immune thrombocytopenic purpura patients
70. Chronic childhood idiopathic thrombocytopenia purpura: Long-term follow-up
71. Idiopathic thrombocytopenic purpura: Long-term outcome
72. Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura
73. The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin
74. Prevention and therapy of bacterial infections for children with asplenia or hyposplenia
75. The site of destruction of autologous 11In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: A study of 578 patients with 268 splenectomies
76. The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura
77. Elective splenectomy in children with idiopathic thrombocytopenic purpura
78. Vinblastine and danazol therapy in steroid resistant childhood chronic idiopathic thrombocytopenic purpura
79. Low-dose cyclosporin A therapy in children with refractory immune thrombocytopenic purpura
80. Treatment of childhood chronic idiopathic thrombocytopenic purpura with ascorbate